Sialoglycosphingolipids (gangliosides) have been increasingly implicated as regulators of membrane signaling events. Macrophage ganglioside patterns dramatically increase in complexity when murine peritoneal macrophages are stimulated in vivo with the appearance of the sialidasesensitive monosialoganglioside GMlb (cisGMl) as a major component Gangliosides from stimulated murine peritoneal macrophages were separated into monosialo and polysialo fractions and the polysialo fraction structurally characterized by enzymatic, chemical, and mass spectra methods. All detectable components of the polysialo fraction were determined to be disialogangliosides. Treatment of the polysialo fraction with Clostridium perfringens sialidase produced mostly the sialidase-resistant monosialoganglioside, GMIa, and a minor amount of asiaJoGMI. Periodate oxidation and mass spectrometry analyses demonstrated the lack of tandem disialo moieties which indicated the absence of GDlb or GDlc (GDI) entities. The combined data showed the major disialogangliosides consisted of GDla entities comprising IV3-NeuAc,II3NeuAc-GgOse4Cer, IV3-NeuGc,II3NeuAc-GgOse4Cer, I V 3 N e u A c , I I 3 N e u G c -G g O s e 4 C e r , and I V 3 -NeuGc,II3NeuGc-GgOse4Cer. Minor components consisted of GDla entities, IV3NeuAc, m6NeuAcGgOse4Cer, IV3NeuGc, III6NeuGcGgOse4Cer, and also positional isomer(s) of GDla(NeuAc, NeuGc). These isomeric components were identified by collision analysis and tandem mass spectrometry. Consistent with previous analyses, the ceramide portion of all polysialo (disialo) gangliosides contained solely C18 sphingosine with C16 and C24 fatty acid moieties. These results, combined with the previous characterization of macrophage monosialogangliosides, indicate normal murine macrophage ganglioside biosynthesis proceeds along the " a " ganglioside pathway, e.g., GM3-»GM2-»GMla->GDla, and the proposed asialoganglioside or " a " pathway, asialoGMl->GMlb->GDltt. The presence of totally sialidase-sensitive gangliosides appears to be characteristic of functional murine peritoneal macrophages while they are reduced in genetically impaired cells.
Introduction
Gangliosides are sialic acid-containing glycosphingolipids found primarily in the plasma membrane of eukaryotic cells. Accumulating evidence indicates these compounds are important components of receptor complexes capable of modulating signal transduction through the membrane (Hakomori and Igarashi, 1995) . In earlier studies we observed dramatic alterations in the ganglioside composition of murine peritoneal macrophages upon macrophage stimulation (Yohe et al., 1985) . Monosialogangliosides fractions were determined to contain a large percentage of sialidase-sensitive GMlb ((also designated cisGMl) (Svennerholm, 1994) ) along with the sialidase resistant GMIa (Yohe et al., 1991) . The polysialoganglioside fractions, however, were not definitively characterized. Based on gas-liquid and thin-layer chromatographic analyses, they were tentatively identified as GDla type disialogangliosides (Yohe et al, 1991; Macala and Yohe, 1995) but some of the data was inconsistent with this suggestion. Specifically, some components bound antiasialoGM 1 antibody after in situ sialidase analyses of thin-layer chromatograms (Yohe et al, 1991) .
Sialidase-sensitive disialogangliosides have been found in a variety of cells. In murine thymoma (Bartoszewicz et al., 1986) and rat T-cells (Nohara et al., 1994) , a disialoganglioside was identified where a tandem disialo moiety is located on the terminal galactose. This disialoganglioside was designated as GDI (Yu, 1994) or GDlc (Iber et al., 1992) , and the biosynthetic precursor to this ganglioside would be Gmlb (Iber et al., 1992) . Another disialoganglioside, designated as GDla, has been described where one sialic acid is linked to the external galactose and the second sialic acid linked to the adjacent N-acetylgalactosamine. GDla was first isolated from frog brain (Ohashi, 1981) and subsequently found in a number of cell lines (Taki et al, 1986 (Taki et al, , 1988 . Hirabayashi et al. (Hirabayashi et al, 1990) found GDla to be a very minor component of bovine brain. Hidari et al (Hidari et al, 1994) and Seyfried et al. (Seyfried et al, 1994) have both directly demonstrated GDla is synthesized from GMlb via an endosialyltransferase. The sialic acid moieties in both GDlc and GDla are readily susceptible to release by sialidase action with neutral gangliotetraosylceraminde (asialoGMl) as the product The presence of these disialogangliosides in cell lines derived from murine immune tissues (Bartoszewicz et al, 1986; Taki et al., 1988) and the presence of GMlb as a major murine elicited peritoneal macrophage ganglioside (Yohe et al, 1991) suggested one or both may be present in murine macrophages.
Upon further investigation of altered murine macrophage ganglioside patterns after macrophage stimulation (Yohe et al, 1985) , we also observed a diminution of sialidase-sensitive GMlb in macrophages from mice widi an impaired stimulus response (Yohe et al., 1991) . In order to clearly assess the functional aspects of these macrophage ganglioside alterations, it became necessary to unambiguously define the polysialo-ganglioside structures present in the stimulated murine macrophage. We have also begun an investigation into the appearance of gangliosides in murine brain tumors which are not present in the cultured tumor cells (Seyfried et al., 1996) . The sialidase-sensitive gangliosides that are relatively absent in normal brain are increasingly present in brain tumors coincident with an increasing number of Fc-receptor bearing cells. The results suggest some novel gangliosides appearing in tumors in vivo are from host infiltrating cells, particularly macrophages. However, to more clearly define the murine model and to use the appropriate antibodies for histological purposes, we also must unambiguously define the murine macrophage polysialoganglioside fraction. For these reasons, we have used chemical, enzymatic, and tandem mass spectrometry methods to examine the polysialoganglioside fraction of stimulated murine macrophages. We report this fraction consists of disialogangliosides having GDI a and GDI a structures which contain N-acetyl, N-glycolyl, and both sialic acid moieties.
Results

HPTLC of the macrophage gangliosides
The total ganglioside fraction (Figure la) was separated into a monosialoganglioside ( Figure lb ) and a polysialoganglioside fraction (Figure lc) . The latter fraction contained 20-32% of the total ganglioside sialic acid as determined by densitometry and exhibited two diagonal parallel series of spots of which the major series (left diagonal series) was -80% of the polysialo fraction (Figure lc ). When treated with sialidase, the predominant products migrated as NeuGc-GMla and NeuAc-GMla ( Figure Id) . However, additional treatment of the chromatogram with orcinol revealed the presence of minor spots that migrated with the sialidase products of macrophage GMlb, i.e., macrophage asialoGMl ( Figure Id) . Treatment of the polysialoganglioside fraction with periodate followed by borohydride reduction and release of the sialic acid moieties revealed only the presence of heptulosaminic acid, the C7 derivative of the parent sialic acid. No trace of intact C9 sialic acid appeared, indicating no tandem sialyl-sialyl linkages were present in this fraction (data not shown).
Mass spectrometry of the polysialoganglioside fraction
Methylation of the total polysialoganglioside fraction followed by ES-MS provided the ion profile shown in The boldface M at the top and left sides of the images indicates the relative mobility of brain GMla in the first and second solvents, respectively. Ganglioside sialic acid was visualized by resorcinol-hydrochloric acid spray and measured by densitometry. In sialidase-treated samples, the location of asialoGMl was determined by orcinol spray and the location is indicated in (d) by the overlapping rings drawn on the image. The monosialoganglioside fraction is identified as determined previously. Each monosialoganglioside type migrated as two sets of doublets, the lower sel of each type contained N-glycolymeuraminic acid, whereas the upper set contained N-acetylneuraminic acid. sodium to yield a molecular weight-related profile without fragmentation (Mr/n + nNa) 1 "". The ion profile indicates the peaks to be doubly charged, (Mr/2 + 2Na) 2+ , and consistent with a series of disialo analogs. Mass coherence between the six components suggests structural similarity in two ways. "), and ion focusing into the collision cell followed by mass analysis of the products, (MS-CID-MS), provided the collision spectra represented in Figures 3-6 . In these spectra, the parent ions showed the expected facile loss of neuraminyl residues and rupture adjacent to hexosaminyl and ceramlde groups (Reinhold et al., 1994) . The results provided information on sequence and sialyl branching and also identified multiple structural isomers within individual peaks. The information was consistent with prior gas-liquid chromatography data (Yohe et al., 1991; Macala and Yohe, 1995) and the chemical data above.
Collision spectra of the smallest mass peak (m/z 1103.0 2+ , Figure 3a ) provided fragments which confirm the glycan components and location of the neuraminyl residues (m/z 398. 2, 472.1, 588.1, 847.2, 828.8 2+ , Figure 3b . These fragments define the structure GDla which was supported by a second ion series with the charge carried by the ceramide terminus (m/z 1808.6, 1432.6, 1357.9, 774.5, 548.6), the latter ion being the ceramide residue itself (Figure 3b) . A C18 sphingosine moiety was indicated by the fragment m/z 278.2, which clarified, by difference, the N-acyl group as a C16 palmityl analog (Figure 3b ).
Several fragments, however, were uncharacteristic of GDla and indicated the fraction also contained an isomeric component with altered sialyl branching. Earlier periodate oxidation studies and the absence of a disialyl fragment, (e.g., m/z 759.4), plus the independent loss of two terminal sialyl residues (m/z 1808.6 and 1432.6), all indicate the fraction was free of tandem sialyl groups, (e.g., there was no GDlb or GDlc present). Several unique fragments, m/z 1208.6, 996.6, and 458.0, localized both sialyl residues of the isomeric component to-the nonreducing terminus following galactosaminyl rupture, (m/z 1208.6, 996.6). This fact was supported by the fragment m/z 1117.8 2+ , Figure 2 ) indicated one of the two sialic acid residues was an N-glycolyl analog (m/z 429.2, Figure 4a ,b); this accounted for the 30 Da increment over the first peak. Fragment ions for Neu5Ac were also observed (m/z 376.3, 398.0), and the presence of both sialic acids was again indicated by their respective loss from the parent ion (m/z 1807.2 and 1836.5). A consecutive loss of both residues was indicated by the ion m/z 1431.7. The N-glycolyl analog introduces an additional component of structural isomerism; two for the N-acetyl and N-glycolyl moieties plus the two for sialyl location. Thus, four structural isomers could be anticipated and all were detected (Figure 4b ). Four major ions elucidate their presence (m/z 1357.7, 1388.8, and 1259.4, 1289.4) . The first ion panare a consequence of rupture adjacent to the hexosylaminyl residue, while the second set represent a combined loss of sialyl and ceramide residues. Ceramide elimination provided a doubly charged ion for the carbohydrate moiety, m/z 843.9 four isomers, which probably accounts for the lower ion abundance.
Ion selection and CID of the third disialoganglioside peak (m/z 1133.2 2+ , Figure 2 ) provided a much simplified spectrum ( Figure 5a) showing a single N-glycolyl sialic acid analog and two isomeric components (Figure 5b ). The sialyl fragment ions were observed as both the protonated and sodiated species, m/z 406.2 and 428.0, respectively. This is affirmed by a single fragment loss (m/z 1837.7). A second terminal loss can also be observed at m/z 1432.2. The products of facile galactosaminyl rupture were observed with the fragments, m/z 1387.7, 1268.4, and 877.0, confirming sialyl location and the presence of two isomers (Figure 5b ). The doubly charged carbohydrate ion, m/z 85S.9 2 *, incremented an additional 30 Da, consistent with both sialyl residues as Neu5Gc. The ceramide mass (m/z 548.6) remained constant in all three peaks of the first set (Figures 3-5, Table I ), indicating C18 sphingosine was the only sphingosine present.
The second set of three peaks, (Figure 2 , m/z 1158.1 2+ , 1173.3 2+ , 1188.2 2+ ), exhibit the same general CID characteristics as their counterpart in the first set. As an example, the CID for 1188.2 2+ is shown in Figure 6a . Differences between the first set and the second set of three peaks were noted only in ceramide containing fragments which were incremented by 110 Da due to a larger N-acyl group on the ceramide residue, (Figure 6b , Table I ). Thus, in this series, the mass data again indicated the ceramide contained only C18 sphingosine but with C24 fatty acyl moieties. Comparable isomers were detected both in sialyl branching and N-glycolyl modifications.
The majority of glycosphingolipid fragments arise by rupture at or rupture adjacent to glycosidic bonds. However, two ions observed in the first CID (m/z 1510.5 and 1381.3, Figure  3a) arose by more complex processes by the respective loss of 671 and 801 Da from the parent ion (m/z 1103 2+ , Table I ). These losses have been observed in a number of sample types, with variations in ceramide and sialyl residues, and have been studied following deuteriomethylation (Reinhold et ai, 1994) . Consistent with the earlier data, the m/z 1381.3 fragment could originate by a cleavage across the internal galactose ring (Figures 3b, 7, top) . The second fragment can be explained by a concerted elimination process and contains an intact ceramide and a single sialyl group (Figure 7, bottom) . Analogous losses were observed upon CID of the parent ion m/z 1117.8 +2 ( Figure  4a ) to yield the fragments m/z 1540.8 and 1412.7, and similar fragments were also prominent in the other CID (Table I ). The combined data support the two ion structures presented in Figure 7 with the m/z observed in each spectrum consistent with the assigned ganglioside structures.
Discussion
Our earlier studies with stimulated murine macrophages indicated the gangliosides are biosynthesized through both the "asialo" and " a " synthetic pathways (Yohe et al., 1991; Ma- cala and Yohe, 1995) . The monosialoganglioside fraction conbut the ceramide moiety of the monosialogangliosides also tained GM3, GM2, sialidase-resistant GMla, and sialidasediffered considerably from that of brain. This polysialogangliosensitive GMlb with entities containing NeuAc and NeuGc side fraction was not completely characterized, but gas-liquid present for all types. Not only was NeuGc sialic acid present chromatographic analyses indicated the fraction consisted pre-dominately, if not solely, of disialogangliosides. Furthermore, HPTLC mobility with some peripheral cell ganglioside standards suggested the fraction contained GDla entities. However, sialidase-treated, two-dimensional thin-layer chromatograms of these macrophage gangliosides displayed a rightmost diagonal series of minor spots that stained positive with antiasialoGMl antibody (Yohe et al, 1991) , data incompatible with a GDla structure. In this report, enzymatic analyses of the isolated polysialo fraction produced mainly the sialidase resistant GMla ganglioside and, with orcinol staining, the presence of a small quantity of asialoGMl. Periodate analyses indicated the absence of any tandem disialo moieties, i.e., an absence of GDlb and GDlc structures.
Using collision-induced dissociation mass spectrometry, the polysialoganglioside fraction of stimulated murine macrophages has been determined to consist of the disialogangliosides GDla and GDla. In all collision spectra of polysialoganglioside parent ions, no ions at m/z 789.8 and 1556.48 (masses for tandem disialo fragments and intact tetraosyl structures) were seen. This, in agreement with the periodate analyses, indicates the absence of GDlc and GDlb. All enzymatic, chemical, and mass spectra data are therefore consistent with GDla and GDla entities. Mass spectra analyses of the monosialoganglioside fraction also confirmed our previously reported structures and additionally indicated the presence of extended GMlb structures (data not shown) which we have observed in a murine myelomonocytic cell line, WEHI-3 (Yohe et al., 1992) . All our prior and current data indicates ganglio series gangliosides are the major components present in murine macrophages. Thus, the gangliosides of stimulated murine macrophages visible by resorcinol staining on twodimensional thin-layer chromatograms can now be indicated as shown in Figure 8 .
Differences in thin layer chromatographic mobilities with brain GDla and the presence of multiple spots on 2D HPTLC (Figures 1, 8 ) appear to be due to differences in the ceramide portion and the presence of N-glycolylneuraminic acid moieties. The results show murine macrophage disialogangliosides contain only C18 sphingosine with the major fatty acid content comprising C16 and C24 moieties, a distribution observed for the macrophage monosialoganglioside fraction (Yohe et al., 1991) , and observed by other investigators for murine T and B cells (Muthing et al, 1987; Portner et al, 1993) .
Having more complete structural detail now allows us to better understand previous observations. From prior GLC distribution of sialic acid types (Macala and Yohe, 1995) , the disialogangliosides can be chromatographically identified as di (NeuGc) entities migrating as the slowest cluster (Figure 8 A reexamination of thin layer chromatograms of macrophages obtained from various strains of mice under different conditions indicated that £.co/i-activated macrophages derived from endotoxin hyporesponsive C3H/HeJ mice often show an increased intensity of the polysialo fraction but rarely show any GDla. This is consistent with the observed increase of GMla and a decrease in GMlb in Zs.co/z-activated macrophages from C3H/HeJ mice and the conclusion that the "asialo" synthetic pathway is decreased or the sialyltransferase-1 (SAT-1) activity (Iber et al., 1992) is increased under these circumstances (Yohe et aL, 1991) . Figure I . The black ellipses indicate solely NeuGc-containing gangliosides, the gray ellipses indicate NeuGc,NeuAc-containing types and the clear ellipses indicate gangliosides that contain solely NeuAc. Numbers in the image correspond to the structures as follows: la, GDla(NeuGc)2; 2a, GDla(NeuGc, NeuAc), 3a,GDla(NeuAc)2; I, GDla(NeuGc)2; 2, GDla (NeuGc, NeuAc); 3, GDla(NeuAc)2; 4, GMlb(NeuGc); 5, GMla(NeuGc); 6, GMlb(NeuAc); 7, GMla(NeuAc), 8, GM2(NeuGc); 9, GM2(NeuAc); 10, GM3(NeuGc); II, GM3(NeuAc). With the exception of la-3ot, numbers are consistent with the prior numbering scheme (Macala and Yohe, 1995) .
Gangliosides have been implicated in the modulation of plasma membrane signal transduction and are now being actively investigated in several laboratories as regulators of membrane signaling events including pathways controlled by tyrosine kinases, protein kinase c, and other kinases (Hakomori and Igarashi, 1995) . Recent evidence demonstrates that brain gangliosides are capable of binding to calmodulin binding sites or calmodulin like peptide structures (Higashi et al, 1996) . Earlier evidence, however, suggested the use of brain derived gangliosides was inappropriate in functional studies on peripheral cell systems (Ryan et al, 1985; Berenson et al, 1991) . We have found brain gangliosides lack specificity in the modulation of murine lymphocyte function (Ryan et al, 1985) . Modulation of macrophage CD4 was far more sensitive to macrophage ganglioside preparations than brain gangliosides (Berenson et al, 1991) . Functional effects and even glycolipid antigenicity is not only dependent on the carbohydrate portion of these compounds but evidence indicates the ceramide structure is important as well (Kannagi et al, 1982 (Kannagi et al, , 1983 Hakomori and Igarashi, 1995) . Unfortunately, the ganglioside structures Disialogangliosldes of elidted murine peritonea] macrophages of many peripheral cell systems have been incompletely defined, making experimental design and interpretation difficult (Ryan et al., 1985) . Knowing the precise structures including the ceramide component of these gangliosides will now permit us to reexamine selected ganglioside-peptide interactions and design experiments, for direct comparisons, using known brain and peripheral ganglioside structures.
Tumors have often been defined by their aberrant glycosylation, particularly shifts in their glycosphingolipids (Hakomori, 1996) . However, our recent evidence suggests some of the unique glycosphingolipids arising in tumors in vivo may come from the infiltrating host macrophages (Seyfried et al., 1996) . Since antiglycosphingolipid antibody use is a proposed therapy, precise identification of metastatic tumor cell versus infiltrating tumor immune cell gangliosides is imperative. With the clear identification of all major components of the macrophage ganglioside fraction, including their ceramide composition, we are also now better able to design studies to locate and to determine the function of these components in murine tumor models.
Materials and methods
Animals and reagents
C3H/HeN and Balb/c female mice (6-8 weeks of age) were obtained from the NEH National Cancer Institute facility at Frederick, MD, and housed in our AAALAC-accredited facility until used. All experiments were carried out under a local Institutional Animal Care and Use Committee approved protocol.
Media and phenol red-free Hank's balanced salt solution (PFHBSS) were obtained from Flow Laboratories, Inc., McLean, VA, or Whittaker MA Bioproducts, Walkersville, MD. Fetal bovine serum (FBS) was purchased from HyClone Laboratories, Logan, UT. All solvents used were high-performance liquid chromatography grade. All chemicals were standard analytical reagent quality.
Isolation of peritoneal cells
Elicited murine peritoneal macrophages were isolated by lavage as described previously (Yohe et al, 1991) . Briefly, elicited peritonea] cells were removed 4 days after i.p. injection of a sterile solution of 10% thioglycolate broth (1 ml/mouse). Cells were removed by peritoneal lavage using 3 x 5-8 ml of PF-HBSS and pooled cell suspensions pelleted by centrifugation at 400 x g for 10 min. The pellet was then resuspended in isotonic pentaerythritol, an aliquot taken for cell counting, and the cell suspension repelleted at 400 x g for 15 min. The isotonic pentaerythritol serves to minimize salts in the lipid extract which could interfere with the subsequent ion exchange chromatography.
Isolation of macrophagc gangliosides
The peritoneal exudate cell gangliosides were isolated by methods previously reported (Yohe et aL, 1991; Macala and Yohe, 1995) . Total lipid extracts are prepared by overnight extraction of the cell pellet using 10 ml chloroform/ methanol (1:1, by voiyiO* cells. To remove membrane fragments, the extracts were filtered through sintered glass funnels (15 ml, medium porosity) overlaid with a glass fiber mat. The filtered residue was rinsed with 3 x 5 ml of chloroform/methanol (1:1, by vol). The combined extracts and rinses were taken to dryness by rotary evaporation. Using a slight modification of our earlier procedure (Yohe et aL, 1991) , the total lipid extract was redissolved, with sonication, in 20 ml of chloroform/methanol/water (30:60:8, by vol) and applied to a 4 ml bed volume column of DEAE-Sephadex A-25, acetate form (Pharmacia, Piscataway, NJ). The neutral lipid fraction was eluted with an additional 30 ml of the same solvent. The acidic lipid fraction, containing the gangliosides, was then eluted with 35 ml of chloroform/methanol/aqueous 0.8 M sodium acetate (30:60:8, by vol). The acidic lipid fraction was taken to dryness by rotary evaporation, redissolved in 5 ml of 0.1 N aqueous NaOH and heated at 37°C for 90 min in a watCT bath to saponify any acidic phospholipids. The sample was chilled in an ice-water bath and the sample pH reduced to 5-6 by adding 0.1 N HC1. The sample was then diluted to 20 ml with chilled water and immediately desalted on a 2 ml bed volume reversed phase silica gel column (SepPak; Waters Associates, Waltham, MA). Each sample was applied to the column three times by passing the first and second eluates back through the same column. Following the third application of sample, flask rinses of 5 ml of 0.1 N NaCl and 2 x 5 ml of water were applied to the column. Remaining salts were eluted with 30 ml of water. Lipids were then eluted with 7 ml of methanol followed by 35 ml of chloroform/methanol (1:2 by vol). The desalting column was regenerated by rinsing with 7 ml of methanol followed by 40-50 ml of water.
The desalted lipid sample was taken to dryness by rotary evaporation, frozen, and then lyophilized to remove all traces of water. The lyophilized sample was dissolved, with sonication, in 1.5 ml of chloroform/methanol (1:1 by vol) followed by 3.5 ml of chloroform, making the final proportion of chloroform/ methanol, 85:15. The sample and two 2.5 ml flask rinses were loaded sequentially onto a 2 ml Iatrobead 6RS-8O60 column (Iatron Laboratories, Tokyo, Japan). Low polarity contaminants were eluted with an additional 10 ml of chloroform/methanol (85:15, by vol). The total ganglioside fraction was eluted with 20 ml of chloroform/methanol (1:2 by vol). After removal of the solvent by rotary evaporation, the purified ganglioside sample was transferred to a 12 x 75 conical screw cap tube with 4 x 1.5 ml rinses of chloroform/methanol (1:2 by vol), and dried under nitrogen. Samples were stored at -20°C until analyzed.
Separation of ganglioside fractions
The fractions were further purified using a 2 ml bed volume column of DEAEToyopearl-650M as described previously (Macala and Yohe, 1995) . The packing was extensively rinsed (-20 column volumes) with methanol, and a total ganglioside sample containing approximately 60 u.g sialic acid was dissolved in 1 ml of methanol and applied to the column. The column was washed with an additional 3 ml of methanol, and then the monosialogangliosidc fraction was eluted with 12 ml of 0.025 M sodium acetate in methanol. The polysialoganglioside fraction was then eluted with 16 ml of 0.05 M sodium acetate in methanol. The methanol was removed by rotary evaporation, and the samples were treated for 30 min at 37°C in 5 ml of 0.1 M aqueous NaOH to cleave any possible lactone formed during the chromatographic process. The separate fractions were then desalted by SepPak chromatography as detailed above and stored at -20°C until analyzed.
HPTLC of the ganglioside fractions
The macrophage ganglioside patterns were examined by two dimensional HPTLC (Yohe et aL, 1988 (Yohe et aL, , 1991 . Briefly, the ganglioside sample (2-5 mg sialic acid) was spotted 15 mm in and up from the lower left corner. A human brain ganglioside standard (0.4 mg sialic) was spotted 5 mm in and 15 mm up from the lower right corner. The plate was chromatographed for 45 min in chloroform/methanol/0.25% aqueous KC\ (50:45:10 by vol) and dried with forced air for 5 min and then over P 2 O 3 for 90 min, in a vacuum desiccator. The dried plate was rotated 90° counter-clockwise, and a second brain ganglioside standard was spotted 5 mm in and 15 mm up from the now lower left corner of the plate. The plate was chromatographed in the second dimension in chloroform/methanol/2.5 N aqueous NH 4 OH containing 0.25% KC1 (50:40:10 by vol) for 30 min. The plates were dried with forced air until the NH 3 odor was gone. Ganglioside sialic acid was visualized by resorcinol-hydrochloric acid spray (Svennerholm, 1957) and the concentration determined by densitometry (Yohe et aL, 1988) .
Sialidase treatment of polysialoganglioside fraction
The isolated polysialoganglioside ganglioside fractions (3-4 mg sialic acid) were dried under nitrogen and lyophilized to remove all traces of organic solvent Clostridium perfringens sialidase (Sigma, St. Louis, MO), 0.5 U in 250 ml of 0.05 M sodium citrate-phosphate buffer at a pH of 5.5, was added to the samples, and the mixtures were incubated at 37 O C for 90 min. The reaction was stopped by adding 2 ml of 0.1 N NaOH and the mixtures were further incubated at 37°C for an additional 30 min to remove any possible lactone. The samples were chilled, acidified, and desalted by SepPak and analyzed by HPTLC.
Periodate oxidation of polysialoganglioside fraction
Polysialoganglioside fractions were subjected to periodate oxidationborohydride reduction to assess the presence of tandem sialic acid linkages (Yohe and Yu, 1981) . The ganglioside samples (6-9 u.g sialic acid), dissolved in chloroform/methanol (1:1 by vol), were put into the tip of a conical 12 ml screwcap test tube and the solvent thoroughly evaporated under nitrogen. Brain ganglioside samples were run simultaneously to verify the process. The samples were dissolved in 270 u.1 of 0.2M acetate buffer (pH 4.4), 30 uJ of 0.5 M sodium periodate added, and then oxidized at 4°C for 48 h. The reaction was stopped by the addition of 50 |xl of 10M ethylene glycol and held an additional 4 h at 4°C. The samples were brought to a pH of 6.5 by the addition of 90 JJLI of cold 0.2N NaOH. Reduction was initiated with the addition of 60 JJLI of 9% sodium borohydride and held overnight at 4°C, (pH 10.5). Samples were neutralized to a pH of 5-6.5 with 70 u.1 of 2 M acetic acid, diluted with 10 ml of 0.1 M NaCl, and desalted on SepPak columns as described above.
The desalted samples were redissolved in a small volume of chloroformimethanol (1:1 by vol) and placed into a 1 ml Reactivial (Pierce, Rockford, IL). The organic solvent was evaporated under nitrogen. The samples were then hydrolyzed with 200 u.1 of 0.05 N aqueous HC1 for 1 h at 80°C. After cooling, the samples were diluted to 1 ml with water and applied to a 0.5 ml bed volume column of AG 1 x4 (acetate form, 200-400 mesh) anion-exchange resin. The columns were rinsed with 10 ml water and the sialic acid eluted with 12.5 ml of 0.3 M acetic acid. The eluates were lyophilized to remove water and acetic acid. The samples were redissolved in 3 x 0.3 ml aliquots of methanol and transferred to a 1 ml Reactivial. After removal of the solvent by nitrogen evaporation, the samples were redissolved in 600 ml of 0.5 M methanolic HC1 and the sialic acids esterified at 60°C for 1 h. After cooling to room temperature, the methanol was evaporated from the samples under nitrogen without the addition of heat.
Sialic acid and N-acetyheptulosaminic acid (C7) standards were prepared as previously described (Yohe and Yu, 1981) . The samples were redissolved in 5-10 u.1 of methanol and spotted on thin layer chromatography plates with the standards and the plates developed in methyl ethyl ketone/glacial acetic acid/ methanol/water (10:4:3:1) for 40 min. The sialic acid esters or analog esters were visualized by the resorcinol spray (Svennerholm, 1957) .
Mass spectrometry of polysialoganglioside fraction
For mass spectral analysis all fractions were methylated by dissolving samples in 200 ml of an NaOH/DMSO suspension, prepared by vortex mixing DMSO and powdered sodium hydroxide (Ciucanu and Kerek, 1984) . After 1 h at room temperature, 50 ml of methyl iodide was added and the solution was set for 1 h at room temperature with occasional vortex mixing. Samples were then partitioned by adding 1 ml of chloroform and the suspension was backextracted four times with 2-3 ml of 30% acetic acid. The chloroform layer was taken to dryness and stored at -20°C (Reinhold et al., 1994) .
Structural characterization of methylated samples was carried out using electrospray ionization-mass spectrometry (ES-MS) with a TSQ 700 triple quadrupole mass spectrometer (Finnigan Corp., San Jose, CA). Samples were dissolved in methanol/water solutions (60:40, v/v) containing 0.25 mM NaOH and analyzed by syringe pump flow injection at a flow rate of 0.85 ml min" 1 directly into the electrospray chamber through a stainless steel hypodermic needle. The voltage difference between the needle tip and the source electrode was 3.5 kV. For collision induced-dissociation (CID) studies, parent ions were selectively transmitted by the first mass analyzer and directed into the collision cell (MS-CED-MS) containing argon at roughly 2 mTorr with acceleration voltages of 30-40 V.
With the exception of the specificity provided by HPTLC, enzymatic release, and periodate oxidation, no direct attempt was undertaken in this work to confirm specific sugar linkage. The structures have been written with the biosynthetic motif, Galp(Bl->3)GalNAcp(|31->4)Galp(31-»4)Glcp(|31->l) ceramide, based on prior toxin binding studies (Mercurio et al., 1984) and antibody plus gas-liquid chromatographic data (Yohe et al., 1991; Macala and Yohe, 1995) . Characterization in this study focused on the remaining problem of ascertaining neuraminic acid position and ceramide heterogeneity.
